| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NPN
|
74,879.00 | 570.6B | 7.01 | 1.50 | 3.67 | 0.8% | 12.1% | 58 | 25 | 76,164.51 | +1.2% | 70 | 0.77 |
|
TFG
|
5,087.00 | 16.0B | 12.19 | 0.64 | 3.68 | -3.3% | 11.8% | 56 | 37 | 7,584.02 | +31.4% | 62 | 1.01 |
|
MRP
|
15,723.00 | 40.2B | 10.78 | 2.76 | 4.62 | 30.1% | 15.3% | 52 | 44 | 10,739.90 | -23.8% | 84 | 1.07 |
|
PIK
|
1,888.00 | 13.9B | — | 1.45 | 5.19 | -4.2% | 13.0% | 44 | 33 | 1,845.78 | -1.1% | 44 | 1.96 |
|
WHL
|
4,199.00 | 37.4B | 15.29 | 3.63 | 6.44 | 17.9% | 14.2% | 43 | 32 | 2,127.93 | -35.5% | 60 | 1.98 |
|
CLS
|
20,249.00 | 46.9B | 14.51 | 7.70 | 7.48 | 47.1% | 16.6% | 42 | 43 | 8,768.26 | -42.5% | 73 | 0.72 |
|
SHP
|
31,431.00 | 170.0B | 22.41 | 5.54 | 8.60 | 17.6% | 15.2% | 42 | 25 | 11,633.78 | -47.2% | 61 | 1.86 |
|
SPP
|
3,854.00 | 7.4B | — | 1.37 | 5.40 | 11.0% | 11.3% | 32 | 40 | 2,709.78 | -17.5% | 36 | 3.12 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.